| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |